These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 2990293
21. Cholinergic function and intellectual decline in Alzheimer's disease. Collerton D. Neuroscience; 1986 Sep; 19(1):1-28. PubMed ID: 3537837 [No Abstract] [Full Text] [Related]
22. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce similar memory impairments in appetitive and non-appetitive behavioral tasks. Hepler D, Wenk G, Olton D, Coyle J. Ann N Y Acad Sci; 1985 Sep; 444():518-9. PubMed ID: 3860114 [No Abstract] [Full Text] [Related]
23. Cholinergic drugs, affective disorders and dementia: problems of clinical research. Spiegel R. Acta Psychiatr Scand Suppl; 1991 Sep; 366():66-9. PubMed ID: 1897378 [No Abstract] [Full Text] [Related]
24. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Pearson RC, Sofroniew MV, Cuello AC, Powell TP, Eckenstein F, Esiri MM, Wilcock GK. Brain Res; 1983 Dec 19; 289(1-2):375-9. PubMed ID: 6362777 [Abstract] [Full Text] [Related]
25. Models of memory dysfunctions. Weingartner H. Ann N Y Acad Sci; 1985 Dec 19; 444():359-69. PubMed ID: 2990294 [No Abstract] [Full Text] [Related]
26. Acetylcholine as a neurotransmitter in the vertebrate retina. Hutchins JB. Exp Eye Res; 1987 Jul 19; 45(1):1-38. PubMed ID: 3308499 [Abstract] [Full Text] [Related]
27. Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy. Brandel JP, Hirsch EC, Malessa S, Duyckaerts C, Cervera P, Agid Y. Neuroscience; 1991 Jul 19; 41(1):25-31. PubMed ID: 2057062 [Abstract] [Full Text] [Related]
28. Rats with nucleus basalis magnocellularis lesions mimic mnemonic symptomatology observed in patients with dementia of the Alzheimer's type. Kesner RP, Adelstein T, Crutcher KA. Behav Neurosci; 1987 Aug 19; 101(4):451-6. PubMed ID: 3651227 [Abstract] [Full Text] [Related]
29. Comparative study of two types of cholinergic lesion in rats. Mayo W. Arch Gerontol Geriatr Suppl; 1989 Aug 19; 1():91-8. PubMed ID: 2667550 [Abstract] [Full Text] [Related]
30. Cholinergic neural regulation of regional cerebral blood flow. Sato A, Sato Y. Alzheimer Dis Assoc Disord; 1995 Aug 19; 9(1):28-38. PubMed ID: 7605619 [Abstract] [Full Text] [Related]
31. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Mesulam MM. Prog Brain Res; 1996 Aug 19; 109():285-97. PubMed ID: 9009717 [No Abstract] [Full Text] [Related]
33. Catecholamine system involvement in age-related memory dysfunction. Zornetzer SF. Ann N Y Acad Sci; 1985 Aug 19; 444():242-54. PubMed ID: 2990292 [No Abstract] [Full Text] [Related]
34. The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. Perry RH, Candy JM, Perry EK, Thompson J, Oakley AE. J Anat; 1984 Jun 19; 138 ( Pt 4)(Pt 4):713-32. PubMed ID: 6746407 [Abstract] [Full Text] [Related]
35. Cholinergic neuropharmacology: an update. Palacios JM, Boddeke HW, Pombo-Villar E. Acta Psychiatr Scand Suppl; 1991 Jun 19; 366():27-33. PubMed ID: 1654727 [Abstract] [Full Text] [Related]
36. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data. Liberini P. Funct Neurol; 1997 Jun 19; 12(3-4):153-7. PubMed ID: 9218969 [No Abstract] [Full Text] [Related]
37. Possible mechanism of Vitis vinifera L. flavones on neurotransmitters, synaptic transmission and related learning and memory in Alzheimer model rats. Ma L, Xiao H, Wen J, Liu Z, He Y, Yuan F. Lipids Health Dis; 2018 Jul 04; 17(1):152. PubMed ID: 29973282 [Abstract] [Full Text] [Related]
38. Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor. Haroutunian V, Kanof PD, Davis KL. Brain Res; 1986 Oct 29; 386(1-2):397-9. PubMed ID: 3779417 [Abstract] [Full Text] [Related]
39. Pharmacological manipulation of the substantia innominata-cortical cholinergic pathway. Wenk GL. Ann N Y Acad Sci; 1985 Oct 29; 444():541-2. PubMed ID: 2990297 [No Abstract] [Full Text] [Related]
40. Cholinergic mechanisms in the rat detrusor muscle. Elmér M. Acta Pharmacol Toxicol (Copenh); 1978 Oct 29; 43 Suppl 2():63-8. PubMed ID: 213938 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]